PTBP1
Polypyrimidine tract-binding protein 1
Also known as: HNRNP-I, HNRPI, pPTB, PTB, PTB-1, PTB2, PTB3, PTB4, PTBP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P26599
- Gene
- PTBP1
- Ensembl
- ENSG00000011304
- Chromosome
- 19
- Canonical length
- 557 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene belongs to the subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are RNA-binding proteins and they complex with heterogeneous nuclear RNA (hnRNA). These proteins are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing and other aspects of mRNA metabolism and transport. While all of the hnRNPs are present in the nucleus, some seem to shuttle between the nucleus and the cytoplasm. The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene has four repeats of quasi-RNA recognition motif (RRM) domains that bind RNAs. This protein binds to the intronic polypyrimidine tracts that requires pre-mRNA splicing and acts via the protein degradation ubiquitin-proteasome pathway. It may also promote the binding of U2 snRNP to pre-mRNAs. This protein is localized in the nucleoplasm and it is also detected in the perinucleolar structure. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
557 residues, UniProt reviewed canonical sequence.
>P26599|PTBP1
1 MDGIVPDIAV GTKRGSDELF STCVTNGPFI MSSNSASAAN GNDSKKFKGD SRSAGVPSRV
61 IHIRKLPIDV TEGEVISLGL PFGKVTNLLM LKGKNQAFIE MNTEEAANTM VNYYTSVTPV
121 LRGQPIYIQF SNHKELKTDS SPNQARAQAA LQAVNSVQSG NLALAASAAA VDAGMAMAGQ
181 SPVLRIIVEN LFYPVTLDVL HQIFSKFGTV LKIITFTKNN QFQALLQYAD PVSAQHAKLS
241 LDGQNIYNAC CTLRIDFSKL TSLNVKYNND KSRDYTRPDL PSGDSQPSLD QTMAAAFGAP
301 GIISASPYAG AGFPPTFAIP QAAGLSVPNV HGALAPLAIP SAAAAAAAAG RIAIPGLAGA
361 GNSVLLVSNL NPERVTPQSL FILFGVYGDV QRVKILFNKK ENALVQMADG NQAQLAMSHL
421 NGHKLHGKPI RITLSKHQNV QLPREGQEDQ GLTKDYGNSP LHRFKKPGSK NFQNIFPPSA
481 TLHLSNIPPS VSEEDLKVLF SSNGGVVKGF KFFQKDRKMA LIQMGSVEEA VQALIDLHNH
541 DLGENHHLRV SFSKSTILocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTBP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 130 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 130 nTPM
- esophagus: 124 nTPM
- skin: 112 nTPM
- liver: 112 nTPM
- spleen: 108 nTPM
- appendix: 99 nTPM
Single-cell type
- extravillous trophoblasts: 204 nCPM
- monocyte progenitors: 185 nCPM
- migrating cytotrophoblasts: 173 nCPM
- erythrocyte progenitors: 167 nCPM
- megakaryocyte progenitors: 164 nCPM
- megakaryocytes: 161 nCPM
Immune cell
- intermediate monocyte: 39 nTPM
- total PBMC: 38 nTPM
- non-classical monocyte: 37 nTPM
- myeloid DC: 36 nTPM
- NK-cell: 34 nTPM
- classical monocyte: 33 nTPM
Brain region
- choroid plexus: 81 nTPM
- medulla oblongata: 54 nTPM
- thalamus: 50 nTPM
- cerebral cortex: 50 nTPM
- midbrain: 49 nTPM
- pons: 49 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PTBP1.
Disease | GeneticClinVar
8 pathogenic / likely-pathogenic of 126 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- PTBP1-related neurodevelopmental disorder with skeletal dysplasia
- STAD syndrome
- Squamous cell carcinoma of the head and neck
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.18
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.65
- DepMap mean gene effect
- -0.37
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- IRES-dependent viral translational initiation
- mRNA processing
- negative regulation of mRNA splicing, via spliceosome
- negative regulation of muscle cell differentiation
- negative regulation of neuron differentiation
- negative regulation of RNA splicing
- neurogenesis
- positive regulation of calcineurin-NFAT signaling cascade
- positive regulation of transcription by RNA polymerase II
- regulation of alternative mRNA splicing, via spliceosome
- regulation of cell differentiation
- regulation of RNA splicing
- RNA splicing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- HnRNP-L/PTB
- Nucleotide-binding alpha-beta plait domain superfamily
- PTBP1-like, RNA recognition motif 2
- RNA-binding domain superfamily
- Heterogeneous nuclear ribonucleoprotein L, RRM domain
- RRM-like domain
- RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain)
- RRM domain
- PTBP1, RNA recognition motif 1
- PTBP1, RNA recognition motif 3
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTBP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTBP1 as an antibody target. Whether an autoantibody or antibody against PTBP1 could matter depends on whether native PTBP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTBP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PTBP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...